Director, US Marketing (HCP & Patient)

Gamida-Cell Inc., an Ayrmid Pharma Ltd. company, is amid a period of transformational growth with a focus on commercializing novel treatments for rare, specialty, and oncological diseases with high unmet need. In support of this evolution, Gamida-Cell is seeking to bring people into the company who have a passion for both helping patients and building corporate capabilities. Are you ready to assist us on that journey? Join us and be instrumental in our growth! Gamida Cell is a leader in advanced cellular therapies and hematopoietic stem cell transplants, with two FDA approved therapies, Omisirge® (omidubicel-onlv) and APHEXDA® (motixafortide). Omisirge® is the first and only FDA approved cell therapy for allogeneic stem cell transplant. APHEXDA® is a stem cell mobilization agent indicated for autologous transplantation for patients with multiple myeloma. The Director, Marketing, will lead the refinement of the strategic marketing plans for our approved products. This individual will also lead many key tactics for both Omisirge® and APHEXDA®. This is a crucial role which will help deliver on the go-to-market strategy in the US, while collaborating with Market Access, Sales, Medical Affairs, Business Analytics, and Operations. The role supports achieving the short and long-term commercial objectives for Gamida-Cell’s programs. This individual must be someone who thrives in a fast-paced environment and is strategic, proactive, and hands-on. The role reports to the Head of US Marketing and Commercial Operations. This is an opportunity which has high corporate visibility; as such, there will be interaction with the leadership teams in the US and abroad.